871266-60-3

Upstream product

• 533-58-4 2-Iodophenol 
• 100-39-0 benzyl bromide 
• 121208-93-3 4-hydroxy-3-iodobenzenesulfonic acid 

Downstream Products

• 871266-61-4 4-benzyloxy-N-tert-butyl-3-iodobenzenesulfonamide 
• 1597414-61-3 (R)-2-{2-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-6,2'-dihydroxy-5'-sulfamoylbiphenyl-3-yl]acetylamino}succinic acid hydrochloride 
• 1597414-60-2 C₄₀H₃₆N₆O₉S*ClH 
• 1597414-62-4 C₄₀H₃₆N₆O₉S*ClH 
• 1597414-59-9 C₂₂H₁₉N₅O₆S*ClH 
• 1597414-58-8 C₄₀H₃₉N₅O₆S*ClH 
• 1597414-57-7 C₃₃H₃₃NO₇S 
• 871266-68-1 (6,2'-bisbenzyloxy-5'-N-tert-butylsulfamoyl-5-formylbiphenyl-3-yl)acetic acid methyl ester 

Relevant academic research and scientific papers

FACTOR VIIA INHIBITOR

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rheumatoid arthritis. Processes for preparing these inhibitors are also disclosed.

LIQUID PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDE

The invention concerns a liquid pharmaceutical composition comprising: A Factor VIIa polypeptide; A buffering agent suitable for keeping pH in the range of from about 5.5 to about 8.5; and An active site stabilizing agent, which is a compound exhibiting a

FACTOR VIIA INHIBITOR

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders

FACTOR VIIA INHIBITOR

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders